BIOCHEMICAL CHARACTERIZATION OF A CANCER IMMUNOTHERAPEUTIC AGENT: MSF-MB = CARACTERISATION BIOCHIMIQUE D'UN AGENT IMMUNOTHERAPEUTIQUE DU CANCER, LE MSF-MBESBER HJ; HAGOPIAN M; BOGDEN AE et al.1974; J. NATION. CANCER INST.; U.S.A.; DA. 1974; VOL. 53; NO 1; PP. 209-212; BIBL. 17REF.Article

POPULATION FREQUENCY OF ERYTHROCYTE ANTIGENS IN THE RHESUS MONKEYBOGDEN AE; GRAY JH; BRULE M et al.1974; LAB. ANIMAL SCI.; U.S.A.; DA. 1974; VOL. 24; NO 6; PP. 910-913; BIBL. 3REF.Article

CIRCADIAN PATTERN OF PROLACTIN AND GROWTH HORMONE LEVELS IN FEMALE RATS OF TWO STRAINS.ESBER HJ; KUO E; BOGDEN AE et al.1976; LAB. ANIMAL SCI.; U.S.A.; DA. 1976; VOL. 26; NO 2 PART. 1; PP. 186-189; BIBL. 23 REF.Article

EFFECT OF SERIAL PASSAGE IN NUDE ATHYMIC MICE ON THE GROWTH CHARACTERISTICS AND CHEMOTHERAPY RESPONSIVENESS OF B762 AND R3230 AC MAMMARY TUMOR XENOGRAFTS.BOGDEN AE; KELTON DE; COBB WR et al.1978; CANCER RES.; U.S.A.; DA. 1978; VOL. 38; NO 1; PP. 59-64; BIBL. 21 REF.Article

COMPARATIVE STUDY ON THE EFFECTS OF SURGERY, CHEMOTHERAPY, AND IMMUNOTHERAPY, ALONE AND IN COMBINATION, ON METASTASES OF THE 13762 MAMMARY ADENOCARCINOMABOGDEN AE; ESBER HJ; TAYLOR DJ et al.1974; CANCER RES.; U.S.A.; DA. 1974; VOL. 34; NO 7; PP. 1627-1631; BIBL. 14REF.Article

3,4-BIS(3'-HYDROXYPHENYL)HEXANE, A NEW MAMMARY TUMOR-INHIBITING COMPOUNDKRANZFELDER G; HARTMANN RW; VON ANGERER E et al.1982; JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; ISSN 0171-5216; DEU; DA. 1982; VOL. 103; NO 2; PP. 165-180; BIBL. 2 P.Article

RESPONSIVENESS OF GYNECOLOGIC TUMORS TO CHEMOTHERAPEUTIE AGENTS IN THE 6-DAY SUBRENAL CAPSULE ASSAY = REPONSE DES TUMEURS GYNECOLOGIQUES A LA CHIMIOTHERAPIE PAR LE TEST DE LA GREFFE SOUS-CAPSULAIRE RENALE DE 6 JOURSHUNTER RE; REICH SD; GRIFFIN TW et al.1982; GYNECOLOGIC ONCOLOGY; ISSN 0090-8258; USA; DA. 1982; VOL. 14; NO 3; PP. 298-306; ABS. ENG; BIBL. 4 REF.; GRAPH, FIGArticle

EFFECTS OF CANCER CHEMOTHERAPEUTIC AGENTS ON ENDOCRINE ORGANS AND SERUM LEVELS OF ESTROGENS, PROGESTERONE, PROLACTIN, AND LUTEINIZING HORMONE. = EFFETS D'AGENTS CHIMIOTHERAPIQUES ANTI-CANCEREUX SUR LES ORGANES ENDOCRINES ET LES TAUX SERIQUES D'OESTROGENES, PROGESTERONE, PROLACTINE ET LHKUO EYH; ESBER HJ; TAYLOR DJ et al.1975; CANCER RES.; U.S.A.; DA. 1975; VOL. 35; NO 8; PP. 1975-1980; BIBL. 25 REF.Article

CHEMOTHERAPY RESPONSIVENESS OF HUMAN TUMORS AS FIRST TRANSPLANT GENERATION XENOGRAFTS IN THE NORMAL MOUSE: SIX DAY SUBRENAL CAPSULE ASSAYBOGDEN AE; COBB WR; LEPAGE DJ et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 48; NO 1; PP. 10-20; BIBL. 6 REF.Article

TOXICITY OF NEOCARZINOSTATIN (NSC-69856): AN ANTITUMOR ANTIBIOTIC WITH RADIOMIMETIC AND ANTIGENIC CHARACTERISTICSSCHAEPPI U; MENNINGER F; FLEISCHMAN RW et al.1974; CANCER CHEMOTHERAPY REP., 3; U.S.A.; DA. 1974; VOL. 5; NO 1; PP. 43-52; BIBL. 14REF.Article

HISTORY OF A RHESUS MONKEY ADENOCARCINOMA CONTAINING VIRUS PARTICLES RESEMBLING ONCOGENIC RNA VIRUSESMASON MM; BOGDEN AE; ILIEVSKI V et al.1972; J. NATION. CANCER INST.,; U.S.A.; DA. 1972; VOL. 48; NO 5; PP. 1323-1331; BIBL. 1P.1/2Serial Issue

THERAPY FOR MOUSE TUMORS AND HUMAN TUMOR XENOGRAFTS WITH THE ANTITUMOR ANTIBIOTIC AT-125HOUCHENS DP; OVEJERA AA; SHERIDAN MA et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 3; PP. 473-476Article

¹⁸F-5-FLUOROURACIL STUDIES IN HUMANS AND ANIMALSLIEBERMAN LM; WESSELS BW; WILEY AL JR et al.1980; INTERNATION. J. RAD. ONCOL. BIOL. PHYS.; USA; DA. 1980; VOL. 6; NO 4; PP. 505-509; BIBL. 9 REF.Article